We are live on ! Find out more
RXST icon

RxSight
RXST

115 hedge funds and large institutions have $637M invested in RxSight in 2023 Q2 according to their latest regulatory filings, with 48 funds opening new positions, 45 increasing their positions, 13 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,345% more call options, than puts

Call options by funds: $1.42M | Put options by funds: $98K

586% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 7

246% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 13

141% more capital invested

Capital invested by funds: $264M → $637M (+$373M)

55% more funds holding

Funds holding: 74 → 115 (+41)

18.17% more ownership

Funds ownership: 46.92% → 65.09% (+18%)

Holders
115
Holders Change
+41
Holders Change %
+55.41%
% of All Funds
1.81%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
48
Increased
45
Reduced
13
Closed
7
Calls
$1.42M
Puts
$98K
Net Calls
+$1.32M
Net Calls Change
+$283K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$32.3M
2
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$24.3M
3
Millennium Management
Millennium Management
New York
+$12.2M
4
ACM
Atika Capital Management
New York
+$11.4M
5
BlackRock
BlackRock
New York
+$8.5M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$20.1M
2
Artisan Partners
Artisan Partners
Wisconsin
-$12.6M
3
BAM
Belpointe Asset Management
Nevada
-$1.76M
4
BM
Bridger Management
New York
-$1.65M
5
MF
Magnetar Financial
Illinois
-$1.47M
Name Holding Trade Value Shares
Change 		Change in
Stake
Invesco
26
Invesco
Georgia
$4.86M +$797K +35,824 +27%
Acadian Asset Management
27
Acadian Asset Management
Massachusetts
$4.81M +$3.4M +152,702 +1,072%
Bank of America
28
Bank of America
North Carolina
$4.45M +$2.67M +120,020 +346%
SSA
29
Schonfeld Strategic Advisors
New York
$4.23M +$523K +23,500 +19%
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
$3.9M +$3.01M +135,496 New
N
31
Nuveen
North Carolina
$3.47M +$1.18M +53,133 +79%
GGHC
32
Gilder Gagnon Howe & Co
New York
$3.44M +$2.66M +119,510 New
Calamos Advisors
33
Calamos Advisors
Illinois
$3.41M +$2.63M +118,286 New
Two Sigma Advisers
34
Two Sigma Advisers
New York
$3.29M +$2.54M +114,100 New
Bank of New York Mellon
35
Bank of New York Mellon
New York
$2.97M +$832K +37,413 +57%
Goldman Sachs
36
Goldman Sachs
New York
$2.9M +$527K +23,710 +31%
AR
37
Advisory Research
Illinois
$2.85M +$2.2M +98,880 New
New York State Common Retirement Fund
38
New York State Common Retirement Fund
New York
$2.7M -$463K -20,818 -18%
Tudor Investment Corp
39
Tudor Investment Corp
Connecticut
$2.45M +$1.89M +84,919 New
CSS
40
Cubist Systematic Strategies
Connecticut
$2.37M +$1.57M +70,386 +598%
JF
41
Jump Financial
Illinois
$2.17M +$1.68M +75,400 New
Jane Street
42
Jane Street
New York
$2.06M +$1.21M +54,360 +314%
Charles Schwab
43
Charles Schwab
California
$2.04M +$226K +10,155 +17%
Deutsche Bank
44
Deutsche Bank
Germany
$1.99M +$1.2M +53,754 +350%
Allspring Global Investments
45
Allspring Global Investments
North Carolina
$1.93M +$1.49M +66,895 New
SEI Investments
46
SEI Investments
Pennsylvania
$1.76M +$541K +24,303 +66%
LCG
47
Lisanti Capital Growth
New York
$1.7M +$1.31M +59,075 New
BFS
48
Bradley Foster & Sargent
Connecticut
$1.65M – – –
Susquehanna International Group
49
Susquehanna International Group
Pennsylvania
$1.57M +$985K +44,261 +434%
HF
50
HRT Financial
New York
$1.33M +$1.02M +46,044 New
1
2
3 4 5

RXST Hedge Fund Activity: Q2 2023 in Review

115 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in RxSight (RXST) for Q2 2023, worth a combined $637M — up 141% from $264M a quarter earlier.

Buyers outnumbered sellers: 48 funds opened new RXST positions and 7 closed out — a net gain of 41 holders — while 45 added to existing stakes and 13 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $32.3M. The largest seller was OrbiMed, exiting entirely with an estimated $20.1M sold.

  • 115 institutional investors held RxSight (RXST) as of Q2 2023, up from 74 in Q1 2023.
  • Funds reported $637M of RxSight stock for Q2 2023, up 141% quarter-over-quarter.
  • 48 funds opened new RxSight positions in Q2 2023 and 7 closed out, a net change of +41 holders.
  • The largest RxSight buyer in Q2 2023 was Morgan Stanley, an estimated $32.3M added.
  • The largest RxSight seller in Q2 2023 was OrbiMed, an estimated $20.1M sold.

Based on aggregated 13F filings for Q2 2023.